Current Environment: Production

Medical Services

Programs & Services

Languages

  • English

Education

Undergraduate School

Queens College, City University of New York

1992, Valhalla, NY

Medical School

New York Medical College

1997, Valhalla, NY

Internship

David Grant USAF Medical Center

1998, Fairfield, CA

Residency

David Grant USAF Medical Center

2001, Fairfield, CA

Fellowship

Boston Children's Hospital

2006, Boston, MA

Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Nephrology)

Professional History

Dr. Traum is originally from New York where he grew up and attended medical school at New York Medical College. After graduation in 1997, he went on active duty in the US Air Force and began his residency in Pediatrics at Travis AFB in northern California. He spent an additional year there as Chief Resident. He then moved east to Andrew AFB outside of Washington, DC where he spent two years as a General Pediatrician. In 2003, he moved to Boston for a fellowship in pediatric nephrology at Boston Children's Hospital. He was a Pediatric Nephrologist at Massachusetts General Hospital from 2006-2015, then returned to Boston Children's in late 2015.

Aside from his clinical interests in the care of children with kidney disease and their families, Dr. Traum has also been involved in the education of medical students and residents. Along with colleagues, he developed and led a novel reflection curriculum for Pediatric Interns, focusing on promoting empathy, preventing burnout, and developing resilience during this early part of their professional identity formation and has promoted more interactive teaching for faculty and residents. His clinical interests span the full spectrum of kidney diseases, transplantation and hypertension.

Publications

  1. A national survey of pediatric nephrologists on the treatment of steroid-resistant nephrotic syndrome. Clin Nephrol. 2025 Jun; 103(6):393-403. View Abstract

  2. Trio exome sequencing in individuals with CAKUT identifies de novo variants in potential novel candidate genes in 19.62. Genet Med. 2025 Apr 10; 101432. View Abstract

  3. Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment. JIMD Rep. 2024 Sep; 65(5):341-353. View Abstract

  4. Derivation and Validation of an Optimal Neutrophil Gelatinase-Associated Lipocalin Cutoff to Predict Stage 2/3 Acute Kidney Injury (AKI) in Critically Ill Children. Kidney Int Rep. 2024 Aug; 9(8):2443-2452. View Abstract

  5. Equity factors in pediatric transplant listing: Initial findings from a single center review. Pediatr Transplant. 2023 03; 27(2):e14467. View Abstract

  6. Clinical presentation and management of nephrotic syndrome in the first year of life: A report from the Pediatric Nephrology Research Consortium. Front Pediatr. 2022; 10:988945. View Abstract

  7. Survival of neonates born with kidney failure during the initial hospitalization. Pediatr Nephrol. 2023 02; 38(2):583-591. View Abstract

  8. Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study. Pediatr Transplant. 2022 05; 26(3):e14202. View Abstract

  9. Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT. Genet Med. 2022 02; 24(2):307-318. View Abstract

  10. Re-transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study. Pediatr Transplant. 2021 Nov; 25(7):e14085. View Abstract

  11. A hemodialysis patient with difficulty ambulating: Questions. Pediatr Nephrol. 2021 Jul; 36(7):2069-2070. View Abstract

  12. A hemodialysis patient with difficulty ambulating: Answers. Pediatr Nephrol. 2021 Jul; 36(7):2071-2073. View Abstract

  13. Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19. Pediatrics. 2021 02; 147(2). View Abstract

  14. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742. View Abstract

  15. Electronic Alerts to Identify Acute Kidney Injury in Children: Promises and Pitfalls. J Pediatr. 2020 05; 220:9-11. View Abstract

  16. Clinical significance of incidentally discovered renal cysts in pediatric patients. Abdom Radiol (NY). 2019 08; 44(8):2835-2840. View Abstract

  17. Promoting Emotional Well-Being Through an Innovative Personal and Professional Development Curriculum for Pediatric Residents. Med Sci Educ. 2019 Dec; 29(4):899-900. View Abstract

  18. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. J Am Soc Nephrol. 2019 02; 30(2):201-215. View Abstract

  19. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol. 2018 09; 29(9):2348-2361. View Abstract

  20. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 04; 71(4):691-699. View Abstract

  21. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 01 06; 13(1):53-62. View Abstract

  22. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View Abstract

  23. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report. Pediatr Transplant. 2017 May; 21(3). View Abstract

  24. Granulomatous interstitial nephritis as a manifestation of Crohn disease. Arch Pathol Lab Med. 2014 Jan; 138(1):125-7. View Abstract

  25. Sensenbrenner syndrome (Cranioectodermal dysplasia): clinical and molecular analyses of 39 patients including two new patients. Am J Med Genet A. 2013 Nov; 161A(11):2762-76. View Abstract

  26. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013 Aug 20; 2(4):e000279. View Abstract

  27. A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection. Pediatr Transplant. 2012 Aug; 16(5):E158-61. View Abstract

  28. Case records of the Massachusetts General Hospital. Case 37-2010. A 16-year-old girl with confusion, anemia, and thrombocytopenia. N Engl J Med. 2010 Dec 09; 363(24):2352-61. View Abstract

  29. Hypertension in the Pediatric Intensive Care Unit. Kiessling SG, Goebel J, Somers MJ, editors. Pediatric Nephrology in the ICU. 2009; 171-182.

  30. Urine proteomic profiling to identify biomarkers of steroid resistance in pediatric nephrotic syndrome. Expert Rev Proteomics. 2008 Oct; 5(5):715-9. View Abstract

  31. The potential for tolerance in pediatric renal transplantation. Curr Opin Organ Transplant. 2008 Oct; 13(5):489-94. View Abstract

  32. The need for tolerance in pediatric organ transplantation. Pediatrics. 2008 Jun; 121(6):1258-60. View Abstract

  33. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant. 2008 Mar; 12(2):180-6. View Abstract

  34. Urinary proteome profiling to search for biomarkers in steroid-resistant nephrotic syndrome. Contrib Nephrol. 2008; 160:29-36. View Abstract

  35. Proteomic analysis in pediatric renal disease. Semin Nephrol. 2007 Nov; 27(6):652-7. View Abstract

  36. Urea Kinetic Modeling for Hemodialysis Presrciption in Children. Nissenson AR & Fine RN, editors. Handbook of Dialysis Therapy. 2007; 1271-1279.

  37. Hypertension. Zaoutis LB & Chiang VW, editors. Comprehensive Pediatric Hospitalist Medicine. 2007; 167-172.

  38. Angiogenesis Inhibition by Thrombospondin-1 in Cyclophosphamide-Treated Pediatric Nephrotic Syndrome [abstract]. Pediatric Research. 2007.

  39. Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol. 2006 Sep; 21(9):1257-65. View Abstract

  40. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients. Pediatr Transplant. 2006 Jun; 10(4):505-12. View Abstract

  41. SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics. 2006 Mar; 6(5):1676-80. View Abstract

  42. Urine Biomarkers Predictive of Steroid Resistance in Nephrotic Syndrome [abstract]. Pediatric Research. 2006.

  43. Transplantation proteomics. Pediatr Transplant. 2005 Dec; 9(6):700-11. View Abstract

  44. Index of suspicion. Case 2. Carbon monoxide (CO) poisoning. Pediatr Rev. 2000 Jan; 21(1):20, 23-4. View Abstract
BESbswy
BESbswy